Systematic review and meta-analysis of cytokeratin 19-based one-step nucleic acid amplification versus histopathology for sentinel lymph node assessment in breast cancer

British Journal of Surgery

Volumn 101, Issue 4, 2014, Pages 298-306

  Tiernan, J P ^a   Verghese, E T ^a   Nair, A ^a   Pathak, S ^a   Kim, B ^a   White, J ^a   Thygesen, H ^a   Horgan, K ^a   Hanby, A M ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19;

BREAST TUMOR; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; META ANALYSIS; METABOLISM; METHODOLOGY; NUCLEIC ACID AMPLIFICATION; PATHOLOGY; PEROPERATIVE CARE; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; STANDARD;

BREAST NEOPLASMS; FEMALE; HUMANS; INTRAOPERATIVE CARE; KERATIN-19; LYMPH NODES; LYMPHATIC METASTASIS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 84894081877     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9386     Document Type: Review

References (38)

1. Cancer Research UK. Breast Cancer Incidence Statistics; 2010. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/breast/incidence/ [accessed 1 January 2013].
2. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 2006; 98: 599-609. (Pubitemid 43904843)
3. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene, FL, Trotti A, (eds). American Joint Committee on Cancer-Cancer Staging Manual (7th edn). Springer: New York, 2010.
4. Solá M, Alberro J, Fraile M, Santesteban P, Ramos M, Fabregas R, et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000. Ann Surg Oncol 2013; 20: 120-127.
5. Pepels MJ, de Boer M, Bult P, van Dijck JA, van Deurzen CH, Menke-Pluymers MB, et al. Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells. Ann Surg 2012; 255: 116-121.
6. Weaver DL, Ashikaga T, Krag DN, Skelly JM, Anderson SJ, Harlow SP, et al. Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 2011; 364: 412-421.
7. Yi M, Giordano S, Meric-Bernstam F, Mittendorf E, Kuerer H, Hwang R, et al. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER Database. Ann Surg Oncol 2010; 17 (Suppl 3): 343-351.
8. Reed J, Rosman M, Verbanac KM, Mannie A, Cheng Z, Tafra L,. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. J Am Coll Surg 2009; 208: 333-340.
9. Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al.; International Breast Cancer Study Group Trial 23-01 investigators. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 2013; 14: 297-305.
10. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011; 305: 569-575.
11. Association of Breast Surgery at Baso 2009. Surgical guidelines for the management of breast cancer. Eur J Surg Oncol 2009; 35 (Suppl 1): S1-S22.
12. Viale G, Dell'Orto P, Biasi MO, Stufano V, De Brito Lima LN, Paganelli G, et al. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg 2008; 247: 136-142.
13. Tsujimoto M, Nakabayashi K, Yoshidome K, Kaneko T, Iwase T, Akiyama F, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 2007; 13: 4807-4816. (Pubitemid 47294788)
14. Tew K, Irwig L, Matthews A, Crowe P, Macaskill P,. Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg 2005; 92: 1068-1080. (Pubitemid 41284870)
15. van de Vrande S, Meijer J, Rijnders A, Klinkenbijl JHG,. The value of intraoperative frozen section examination of sentinel lymph nodes in breast cancer. Eur J Surg Oncol 2009; 35: 276-280.
16. US Food and Drug Administration. GeneSearch™ BLN Test Kit-P060017. http://www.fda.gov/medicaldevices/productsandmedicalprocedures/ deviceapprovalsandclearances/recently-approveddevices/ucm076681.htm [accessed 1 January 2013].
17. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000; 28: E63.
18. Louis TA, Lavori PW, Bailar JC III, Polansky M,. Crossover and self-controlled designs in clinical research. N Engl J Med 1984; 310: 24-31. (Pubitemid 14212477)
19. Bernet L, Cano R, Martinez M, Dueñas B, Matias-Guiu X, Morell L, et al. Diagnosis of the sentinel lymph node in breast cancer: a reproducible molecular method: a multicentric Spanish study. Histopathology 2011; 58: 863-869.
20. Feldman S, Krishnamurthy S, Gillanders W, Gittleman M, Beitsch PD, Young PR, et al.; US One Step Nucleic Acid Amplification Clinical Study Group. A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes. Cancer 2011; 117: 2599-2607.
21. Khaddage A, Berremila SA, Forest F, Clemenson A, Bouteille C, Seffert P, et al. Implementation of molecular intra-operative assessment of sentinel lymph node in breast cancer. Anticancer Res 2011; 31: 585-590.
22. Le Frère-Belda MA, Bats AS, Gillaizeau F, Poulet B, Clough KB, Nos C, et al. Diagnostic performance of one-step nucleic acid amplification for intraoperative sentinel node metastasis detection in breast cancer patients. Int J Cancer 2011; 130: 2377-2386.
23. Sagara Y, Ohi Y, Matsukata A, Yotsumoto D, Baba S, Tamada S, et al. Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer. Breast Cancer 2013; 20: 181-186.
24. Schem C, Maass N, Bauerschlag DO, Carstensen MH, Löning T, Roder C, et al. One-step nucleic acid amplification-a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group. Virchows Arch 2009; 454: 203-210.
25. Snook KL, Layer GT, Jackson PA, de Vries CS, Shousha S, Sinnett HD, et al.; OSNA Study Group. Multicentre evaluation of intraoperative molecular analysis of sentinel lymph nodes in breast carcinoma. Br J Surg 2011; 98: 527-535.
26. Tamaki Y, Akiyama F, Iwase T, Kaneko T, Tsuda H, Sato K, et al. Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res 2009; 15: 2879-2884.
27. Visser M, Jiwa M, Horstman A, Brink AA, Pol RP, van Diest P, et al. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer 2008; 122: 2562-2567. (Pubitemid 351590490)
28. Wang YS, Ou-yang T, Wu J, Liu YH, Cao XC, Sun X, et al. Comparative study of one-step nucleic acid amplification assay, frozen section, and touch imprint cytology for intraoperative assessment of breast sentinel lymph node in Chinese patients. Cancer Sci 2012; 103: 1989-1993.
29. Royal College of Surgeons of England. National Mastectomy and Breast Reconstruction Audit 2011. http://www.rcseng.ac.uk/surgeons/research/surgical- research/docs/national-mastectomy-and-breast-reconstruction-audit-fourth-report- 2011 [accessed 14 November 2013].
30. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J,. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 2006; 6: 9.
31. Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumencranz PW, Reintgen DS, et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA 2011; 306: 385-393.
32. Burke M, Patton T,. NHS Technology Adoption Centre: The Cost Impact of Implementing IntraOperative Testing for the Diagnosis of Patients with Metastatic Breast Cancer in England; 2010. http://www.ntac.nhs.uk/web/FILES/ BreastLymphNode/nhs-1290615229-Economic-report.pdf [accessed 14 November 2013].
33. NHS Breast Screening Programme and Association of Breast Surgery. An Audit of Screen Detected Breast Cancers for the Year of Screening April 2010 to March 2011. http://www.cancerscreening.nhs.uk/breastscreen/publications/ baso2010-2011.pdf [accessed 14 November 2013].
34. Altman DG, Bland JM,. Statistics Notes: diagnostic tests 2: predictive values. BMJ 1994; 309: 102. (Pubitemid 24216428)
35. Warner J., Clinicians' guide to evaluating diagnostic and screening tests in psychiatry. Adv Psychiatr Treat 2004; 10: 446-454. (Pubitemid 39504584)
36. Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 2004; 203: 661-671. (Pubitemid 38714103)
37. Parikh RR, Yang Q, Higgins SA, Haffty BG,. Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression. Int J Radiat Oncol Biol Phys 2008; 70: 35-42. (Pubitemid 350251027)
38. Association of Breast Surgery. Yearbook 2012. http://www. associationofbreastsurgery.org.uk/media/8908/abs-yearbook-2012-web.pdf [accessed 1 January 2013].